Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) issued its quarterly earnings data on Thursday. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.21 by $0.08, FiscalAI reports. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The company had revenue of $7.30 billion during the quarter. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year.
Here are the key takeaways from Marsh & McLennan Companies’ conference call:
- Q1 results — Revenue rose 8% to $7.6 billion (4% underlying), adjusted operating income and adjusted EPS each grew 8% (adjusted EPS $3.29), and the company repurchased $750 million of stock while guiding to similar underlying revenue growth in 2026 with continued margin expansion.
- AI strategy — Marsh is investing heavily in AI across three pillars (growth, productivity, efficiency) with products like Ada, Sentrisk, Euclid and GC QuoteBox and early wins (e.g., document ingestion improving efficiency ~20%), which management says will fund growth investments and support margin improvement.
- Legal charge — The quarter included a $425 million charge related to ongoing litigation stemming from the Greensill Capital collapse, recorded as the company’s best estimate of liability after mediation; the matter remains unresolved.
- Market and interest-rate headwinds — Pricing pressure persists (Marsh index: primary commercial rates down 5%, global property down 9%; reinsurance non-loss accounts down 15–20%) and fiduciary interest income declined $18 million to $85 million in Q1, with Q2 fiduciary income expected around $80 million.
- Capital deployment — Management expects to deploy about $5 billion of capital in 2026 across dividends, acquisitions and buybacks (balanced, disciplined approach), and says the M&A pipeline is active while buybacks will flex with acquisition activity.
Marsh & McLennan Companies Stock Down 3.4%
Shares of NYSE MRSH opened at $176.35 on Friday. Marsh & McLennan Companies has a fifty-two week low of $164.89 and a fifty-two week high of $235.78. The company’s 50-day moving average is $173.66. The company has a current ratio of 1.11, a quick ratio of 1.10 and a debt-to-equity ratio of 1.28. The company has a market capitalization of $85.38 billion, a PE ratio of 22.04, a P/E/G ratio of 2.51 and a beta of 0.75.
Marsh & McLennan Companies Announces Dividend
Insider Transactions at Marsh & McLennan Companies
In related news, CEO John Q. Doyle sold 16,655 shares of Marsh & McLennan Companies stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the transaction, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $21,411,456.30. The trade was a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.38% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Marsh & McLennan Companies
Institutional investors have recently bought and sold shares of the stock. Pinnacle Bancorp Inc. purchased a new position in Marsh & McLennan Companies during the 3rd quarter valued at about $25,000. Solstein Capital LLC purchased a new position in Marsh & McLennan Companies during the 4th quarter valued at about $25,000. SHP Wealth Management purchased a new position in Marsh & McLennan Companies during the 4th quarter valued at about $26,000. KERR FINANCIAL PLANNING Corp purchased a new position in Marsh & McLennan Companies during the 4th quarter valued at about $27,000. Finally, Golden State Wealth Management LLC purchased a new position in Marsh & McLennan Companies during the 4th quarter valued at about $27,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.
Analyst Ratings Changes
MRSH has been the subject of a number of recent analyst reports. Keefe, Bruyette & Woods raised their price target on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “market perform” rating in a research report on Friday. Morgan Stanley decreased their price target on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a research report on Monday, April 6th. Barclays decreased their price target on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. Evercore decreased their price target on shares of Marsh & McLennan Companies from $237.00 to $236.00 and set an “outperform” rating for the company in a research report on Wednesday, January 7th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and set a $200.00 price target on shares of Marsh & McLennan Companies in a research report on Friday, January 30th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $205.33.
Check Out Our Latest Research Report on MRSH
Key Headlines Impacting Marsh & McLennan Companies
Here are the key news stories impacting Marsh & McLennan Companies this week:
- Positive Sentiment: Q1 results beat expectations — non‑GAAP EPS $3.29 vs. ~$3.21 estimate and revenue roughly $7.3B with ~8% year‑over‑year growth; Mercer/consulting drove strength. Marsh (MRSH) Beats Q1 Earnings and Revenue Estimates
- Positive Sentiment: Earnings call highlighted continued growth initiatives and AI investments that management says support long‑term revenue/consulting momentum — a potential positive catalyst for future margins. Marsh & McLennan Earnings Call Highlights Growth and AI
- Positive Sentiment: Keefe, Bruyette & Woods raised its price target to $203 (market‑perform), implying upside from current levels — a modest vote of confidence from an analyst. Price Target Raise
- Neutral Sentiment: Commentary and analyst pieces note that valuation looks more attractive after the pullback — could attract value buyers but depends on execution and margin trends. Marsh & McLennan: The Valuation May Finally Be Here
- Negative Sentiment: Bank of America maintained a sell rating on MRSH, providing a counterweight to upbeat results and likely contributing to short‑term selling pressure. Bank of America Sticks to Sell Rating
- Negative Sentiment: Company disclosed a new regulation‑category risk that could materially affect financial performance — an added uncertainty that can weigh on sentiment until clarified. Regulatory Risk Disclosure
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Stories
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
